Novel Drug Reduced Bulging in Active and Chronic Thyroid Eye Disease

By News Health
3 months Ago

(MedPage Today) — ORLANDO — Infusions of the investigational monoclonal antibody veligrotug improved symptoms among patients with active and chronic thyroid eye disease, the phase III THRIVE clinical program showed.
By week 15 in 113 patients…

Source link : https://www.medpagetoday.com/meetingcoverage/aace/115658

Author :

Publish date : 2025-05-19 19:34:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

RFK Jr. Quietly Endorses Flu Vaccine for Kids and Adults

Daily weight loss pill helps patients lose 12% of body weight

Can Colistin-Meropenem Synergy Combat Resistant Infections?

Other Lymphomas May Be Linked to Post-Mastectomy Breast Implants

Looming Pay Cut to LAAO Triggers Objection From Card Groups

Genital Ultrasound Crime; Doc Gets 12 Years for Killing Wife; Nurse Impostor Arrest